Emergence of Clostridium difficile Ribotype 027 in Korea
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Background: Clostridium difficile infection (CDI) has markedly risen and is associated with hypervirulent ribotype 027 outbreaks in North America and Europe since 2003. The aims of this study were to determine the prevalence of ribotype 027 among C. difficile isolates in Korea, to characterize the ribotype 027 isolates, and to determine the clinical severity of CDI in patients infected with these isolates. Methods: A total of 1,251 isolates of C. difficile recovered from stool specimens of suspected CDI patients at two tertiary-care hospitals and one commercial laboratory between 2002 and 2009. Genes for toxin A (tcdA), toxin B (tcdB), and binary toxin (cdtA and cdtB) were detected by PCR. Mutation in the tcdC gene was detected by sequencing after PCR amplification. For molecular genotyping, we performed PCR-ribotyping, pulsed-field gel electrophoresis (PFGE), and multilocus variable-number tandem-repeat analysis (MLVA). Minimum inhibitory concentrations of moxifloxacin were determined using Etest strips (AB bioMérieux, Sweden). Results: We identified 7 isolates as ribotype 027. These isolates had the same tcdC mutation as the epidemic strain, and 6 of them were resistant to moxifloxacin. The isolates were categorized into 3 different PFGE types and 7 different MLVA types. All the 7 cases had occurred sporadically. Conclusions: C. difficile ribotype 027 is uncommon, but it has emerged in Korea. The spread of this ribotype should be closely monitored in order to avoid an outbreak of CDI in Korea.
Abstract
Background: Clostridium difficile infection (CDI) has markedly risen and is associated with hypervirulent ribotype 027 outbreaks in North America and Europe since 2003. The aims of this study were to determine the prevalence of ribotype 027 among C. difficile isolates in Korea, to characterize the ribotype 027 isolates, and to determine the clinical severity of CDI in patients infected with these isolates. Methods: A total of 1,251 isolates of C. difficile recovered from stool specimens of suspected CDI patients at two tertiary-care hospitals and one commercial laboratory between 2002 and 2009. Genes for toxin A (tcdA), toxin B (tcdB), and binary toxin (cdtA and cdtB) were detected by PCR. Mutation in the tcdC gene was detected by sequencing after PCR amplification. For molecular genotyping, we performed PCR-ribotyping, pulsed-field gel electrophoresis (PFGE), and multilocus variable-number tandem-repeat analysis (MLVA). Minimum inhibitory concentrations of moxifloxacin were determined using Etest strips (AB bioMérieux, Sweden). Results: We identified 7 isolates as ribotype 027. These isolates had the same tcdC mutation as the epidemic strain, and 6 of them were resistant to moxifloxacin. The isolates were categorized into 3 different PFGE types and 7 different MLVA types. All the 7 cases had occurred sporadically. Conclusions: C. difficile ribotype 027 is uncommon, but it has emerged in Korea. The spread of this ribotype should be closely monitored in order to avoid an outbreak of CDI in Korea.
참고문헌 (15)
- Warny M, "Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe", Lancet, 366, pp.1079~1084 (2005)
- Cheng VC, "Clostridium difficile ribotype 027 arrives in Hong Kong", Int J Antimicrob Agents, 34, pp.492~493 (2009)
- Kato H, "First isolation of Clostridium difficile 027 in Japan", Euro Surveill, 12 (2007)
- 태정현, "The First Case of Antibiotic-associated Colitis by Clostridium difficile PCR Ribotype 027 in Korea", Journal of Korean Medical Science, 24(3), pp.520~524 (2009), 대한의학회
- McDonald LC, "An epidemic, toxin gene-variant strain of Clostridium difficile", N Engl J Med, 353, pp.2433~2441 (2005)
- Zar FA, "A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity", Clin Infect Dis, 45, pp.302~307 (2007)
- Terhes G, "Community-acqu-ired Clostridium difficile diarrhea caused by binary toxin, toxin A, and toxin B gene-positive isolates in Hungary", J Clin Microbiol, 42, pp.4316~4318 (2004)
- Spigaglia P, "Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods", J Med Microbiol, 53, pp.1129~1136 (2004)
- O’Neill GL, "Modification of a PCR ribotyping method for application as a routine typing sch-eme for Clostridium difficile", Anaerobe, 2, pp.205~209 (1996)
- Alonso R, "An improved protocol for pulsed-field gel electrophoresis typing of Clostridium difficile", J Med Microbiol, 54, pp.155~157 (2005)
- Kim SJ, "Molecular characterization of toxin A-negative, toxin B-positive variant stra-ins of Clostridium difficile isolated in Korea", Diagn Microbiol Infect Dis, 67, pp.198~201 (2010)
- Marsh JW, "Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals", J Clin Microbiol, 44, pp.2558~2566 (2006)
- Morgan OW, "Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study", PLoS One, 3, pp.1812~ (2008)
- Pépin J, "Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity", CMAJ, 171, pp.466~472 (2004)
- Jung SW, "Clinical aspects of rifampicin-associated pseudomembranous colitis", J Clin Gastroenterol, 41, pp.38~40 (2007)